Melar Acquisition Corp. I Completes $160 Million Initial Public Offering
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jun 20 2024
0mins
Should l Buy MACIU?
Source: Newsfilter
- Initial Public Offering Details: Melar Acquisition Corp. I closed its IPO of 16,000,000 units priced at $10.00 per unit, raising $160,000,000.
- Trading Information: The company's units started trading on Nasdaq under the symbol "MACIU," with plans for separate listings of shares and warrants.
- Proceeds Allocation: $160,000,000 from the offering was placed in the Company's trust account for future use.
- Company Leadership: Led by Gautam Ivatury (CEO and Chairman), Edward Lifshitz (CFO), and Eric Lifshitz (COO and Director).
- Underwriters and Registration: Cohen & Company Capital Markets and Seaport Global Securities were involved, with a registration statement declared effective by the SEC.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy MACIU?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on MACIU
Wall Street analysts forecast MACIU stock price to rise
0 Analyst Rating
0 Buy
0 Hold
0 Sell
Current: 11.940
Low
Averages
High
Current: 11.940
Low
Averages
High
No data
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Everli, A Major Italian E-Grocery Marketplace, Signs Agreement To Go Public Via $180 Million Business Combination With Melar Acquisition Corp. I
Everli's Merger Announcement: Everli, an Italian e-grocery platform, has entered a merger agreement with Melar Acquisition Corp., valuing the company at $180 million and aiming for a Nasdaq listing under the name Everli Global Holdings Inc.
Growth and Market Strategy: The merger is expected to accelerate Everli's growth, enhance its technology, and expand its market presence in Europe, capitalizing on the projected growth of the Italian e-grocery market to $12 billion by 2030.
See More
Melar Acquisition Corp. I Completes $160 Million Initial Public Offering
- Initial Public Offering Details: Melar Acquisition Corp. I closed its IPO of 16,000,000 units priced at $10.00 per unit, raising $160,000,000.
- Trading Information: The company's units started trading on Nasdaq under the symbol "MACIU," with plans for separate listings of shares and warrants.
- Proceeds Allocation: $160,000,000 from the offering was placed in the Company's trust account for future use.
- Company Leadership: Led by Gautam Ivatury (CEO and Chairman), Edward Lifshitz (CFO), and Eric Lifshitz (COO and Director).
- Underwriters and Registration: Cohen & Company Capital Markets and Seaport Global Securities were involved, with a registration statement declared effective by the SEC.
See More
IPO roundup: Lionheart Holdings, Melar Acquisition Corp. I, and more
IPO Market Highlights:
- Tempus AI had a successful IPO debut, while Telix Pharmaceuticals withdrew its IPO due to market conditions.
- Renaissance IPO ETF is up 5.75% YTD, compared to the S&P 500's 15% increase.
Upcoming IPOs/SPACs:
- Various companies like Flag Ship Acquisition, Lionheart Holdings, and Melar Acquisition Corp. I are raising funds through IPOs.
- Nova Minerals, OS Therapies, and EShallGo are also planning IPOs.
New Filings:
- Companies like Concentra Group Holdings Parent, CF Acquisition A, Star Fashion Culture Holdings, Lithium Harvest, NIP Group, and Launch One Acquisition have filed for IPOs.
Terms and Changes:
- Tamboran Resources, Actuate Therapeutics, LandBridge, WEBTOON Entertainment, and Zhengye Biotechnology Holding have set terms for their IPOs.
Withdrawal:
- Telix Pharmaceuticals withdrew its IPO plans in the U.S. due to current market conditions.
See More
Everli, A Major Italian E-Grocery Marketplace, Signs Agreement To Go Public Via $180 Million Business Combination With Melar Acquisition Corp. I
Everli's Merger Announcement: Everli, an Italian e-grocery platform, has entered a merger agreement with Melar Acquisition Corp., valuing the company at $180 million and aiming for a Nasdaq listing under the name Everli Global Holdings Inc.
Growth and Market Strategy: The merger is expected to accelerate Everli's growth, enhance its technology, and expand its market presence in Europe, capitalizing on the projected growth of the Italian e-grocery market to $12 billion by 2030.
See More
Melar Acquisition Corp. I Completes $160 Million Initial Public Offering
- Initial Public Offering Details: Melar Acquisition Corp. I closed its IPO of 16,000,000 units priced at $10.00 per unit, raising $160,000,000.
- Trading Information: The company's units started trading on Nasdaq under the symbol "MACIU," with plans for separate listings of shares and warrants.
- Proceeds Allocation: $160,000,000 from the offering was placed in the Company's trust account for future use.
- Company Leadership: Led by Gautam Ivatury (CEO and Chairman), Edward Lifshitz (CFO), and Eric Lifshitz (COO and Director).
- Underwriters and Registration: Cohen & Company Capital Markets and Seaport Global Securities were involved, with a registration statement declared effective by the SEC.
See More
IPO roundup: Lionheart Holdings, Melar Acquisition Corp. I, and more
IPO Market Highlights:
- Tempus AI had a successful IPO debut, while Telix Pharmaceuticals withdrew its IPO due to market conditions.
- Renaissance IPO ETF is up 5.75% YTD, compared to the S&P 500's 15% increase.
Upcoming IPOs/SPACs:
- Various companies like Flag Ship Acquisition, Lionheart Holdings, and Melar Acquisition Corp. I are raising funds through IPOs.
- Nova Minerals, OS Therapies, and EShallGo are also planning IPOs.
New Filings:
- Companies like Concentra Group Holdings Parent, CF Acquisition A, Star Fashion Culture Holdings, Lithium Harvest, NIP Group, and Launch One Acquisition have filed for IPOs.
Terms and Changes:
- Tamboran Resources, Actuate Therapeutics, LandBridge, WEBTOON Entertainment, and Zhengye Biotechnology Holding have set terms for their IPOs.
Withdrawal:
- Telix Pharmaceuticals withdrew its IPO plans in the U.S. due to current market conditions.
See More
